Andersen Group stock jumps 5% as Franklin Resources reveals 7.9% stake
30 January 2026
1 min read

Andersen Group stock jumps 5% as Franklin Resources reveals 7.9% stake

New York, Jan 30, 2026, 15:24 (EST) — Regular session

Shares of Andersen Group Inc climbed roughly 4.6% to $22.39 in New York afternoon trading, bouncing between $21.40 and $22.92 earlier in the session.

This move is significant since the stock is still finding its footing as a new listing, with ownership and liquidity in flux. New stake disclosures help clarify the landscape, particularly when the float remains tight and trading remains volatile.

A regulatory filing revealed Franklin Resources holds beneficial ownership of 997,468 Andersen Group shares, representing 7.9% of the class. The Schedule 13G, a short-form disclosure for investors not pursuing control, cites Dec. 31, 2025, as the relevant “event” date. 1

Andersen Group went public on the New York Stock Exchange in December, setting its IPO price at $16 per share. CEO Mark Vorsatz noted the move would provide the firm with “new currency to pursue deals and fuel expansion.” 2

Friday’s rebound also reflects investors grappling with the true level of institutional demand and how fast it’s gaining momentum. While a stake filing might signal fresh, steady inflows, it can just as easily reveal positions already held.

Andersen Group is set to release its quarterly results on Feb. 25, the next major date to watch, according to market data from The Wall Street Journal. 3

New stocks can still move on momentum instead of fundamentals. Andersen Group flagged this risk in its IPO filing, cautioning that future share sales and issuances might drag the price down, particularly once resale restrictions expire. 4

Stock Market Today

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
NIO stock jumps on profit alert, with Monday’s open in focus

NIO stock jumps on profit alert, with Monday’s open in focus

7 February 2026
NIO shares jumped 7.23% to $5.04 Friday after the company forecast a swing to adjusted operating profit of up to 1.2 billion yuan for the fourth quarter. Trading volume reached 90.8 million shares, far above average. Nio’s deliveries rose 72% to 124,807 vehicles in the quarter. The company said results are preliminary and unaudited, with final figures due in March.
Snap stock price bounces to $5.22 after upgrades — what traders watch next week

Snap stock price bounces to $5.22 after upgrades — what traders watch next week

7 February 2026
Snap Inc. shares closed up 2% at $5.22 Friday after a volatile week, with 94 million shares traded. The company forecast Q1 revenue below analyst expectations, despite a fourth-quarter beat and a 28% rise in active advertisers. Daily active users fell by 3 million to 474 million. Analysts remain divided, with some upgrading and others trimming price targets.
ImmunityBio stock rebounds: FDA scrutiny, a $505 million note and the next catalyst for IBRX
Previous Story

ImmunityBio stock rebounds: FDA scrutiny, a $505 million note and the next catalyst for IBRX

Starbucks stock drops near $92 as investors weigh 2028 margin push after a busy week
Next Story

Starbucks stock drops near $92 as investors weigh 2028 margin push after a busy week

Go toTop